TroponinT After Subcutaneous Cardioverter-Defibrillator Implantation

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03526302

Acronym

TROPIC

Enrollment

Registered

2018-05-16

Start date

2018-04-01

Completion date

2020-09-30

Last updated

2023-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sudden Cardiac Death

Brief summary

Serum Troponin levels pre- and postoperatively will be compared in patients receiving an entirely subcutaneous cardioverter-defibrillator.

Detailed description

To analyze the periprocedural myocardial damage the pre- and postoperative assessment of serum levels of high sensitive TroponinT (hsTnT) is done. The main objectives of the TROPIC register are to evaluate the level of high sensitive TroponinT before and after S-ICD device implantation and to compare these changes in TroponinT-levels with those after standard transvenous ICD-implantation.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Indication for the implantation of an entirely subcutaneous cardioverter-defibrillator

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame	Description
High sensitive TroponinT	24 hours	Difference between pre- and postoperative high sensitive TroponinT serum levels

Countries

Germany

Outcome results